| Sanofi-Aventis (Suisse) SA - Renvela, comprimé pelliculé | | 61648 | | 01 | | Renvela | | comprimé pelliculé | | V03AE02 | | Sevelamer | | 10.11.2011 | | |
| | Composition | | sevelameri carbonas 800 mg, natrii chloridum corresp. natrium 1.26 mg, cellulosum microcristallinum, zinci stearas, pellicule: hypromellosum, monoglyceriderorum diacetylates, encre: hypromellosum, propylenglycolum, E 172 (nigrum), pro compresso obducto. | | Packungsbestandteile | | Coated tablets | | | | | Active Agent | Dose |
|---|
| Sevelameri Carbonas | 800 mg |
| | BAG: Active Agent | Dose |
|---|
| Sevelameri Carbonas | 800 mg |
| | | | Inactive agents | | additional_information |
|---|
| (Nigrum) | | | | Cellulosum Microcristallinum | | | | E 172 | | color. | | Hypromellosum | | encre | | Monoglyceriderorum Diacetylates | | | | Sodium Chloride | | | | Pro Compresso Obducto | | | | Propylenglycol | | | | Zinc Stearate | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 001 | 180 Tablet(s) | 141.67 | 169.25 | B | SL | Yes |
|
|
